Literature DB >> 10563653

APOE-491 promoter polymorphism is a risk factor for late-onset Alzheimer's disease.

V M Casadei1, C Ferri, F Veglia, A Gavazzi, G Salani, M Cattaneo, S Sorbi, G Annoni, F Licastro, C Mariani, M Franceschi, L M Grimaldi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10563653     DOI： 10.1212/wnl.53.8.1888

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

Review 1.  The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review.

Authors:  R A Nixon; A M Cataldo; P M Mathews
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

2.  ApoE -491A/T promoter polymorphism is not an independent risk factor, but associated with the epsilon4 allele in Hungarian Alzheimer's dementia population.

Authors:  Anna Juhász; András Palotás; Zoltán Janka; Agnes Rimanóczy; Miklós Palotás; Nikoletta Bódi; Krisztina Boda; Marianna Zana; Gábor Vincze; János Kálmán
Journal:  Neurochem Res       Date:  2005-05       Impact factor: 3.996

3.  Association between Alzheimer disease and the -491T allele of regulatory region polymorphism of Apolipoprotein E in a Tunisian population.

Authors:  Afef Achouri-Rassas; Sondes Hadj Fredj; Hela Mrabet Khiari; Amina Bibi; Hajer Siala; Amel Mrabet; Taieb Messaoud
Journal:  Neurochem Res       Date:  2013-12-11       Impact factor: 3.996

4.  The complex interaction between APOE promoter and AD: an Italian case-control study.

Authors:  Alessandra Bizzarro; Davide Seripa; Adele Acciarri; Maria Giovanna Matera; Alberto Pilotto; Francesco Danilo Tiziano; Christina Brahe; Carlo Masullo
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

5.  Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.

Authors:  Kristin K Nicodemus; Judith E Stenger; Donald E Schmechel; Kathleen A Welsh-Bohmer; Ann M Saunders; Allen D Roses; John R Gilbert; Jeffery M Vance; Jonathan L Haines; Margaret A Pericak-Vance; Eden R Martin
Journal:  Neurogenetics       Date:  2004-09-29       Impact factor: 2.660

6.  Functional characterization of three single-nucleotide polymorphisms present in the human APOE promoter sequence: Differential effects in neuronal cells and on DNA-protein interactions.

Authors:  Bryan Maloney; Yuan-Wen Ge; Ronald C Petersen; John Hardy; Jack T Rogers; Jordi Pérez-Tur; Debomoy K Lahiri
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-01-05       Impact factor: 3.568

7.  Influence of multiple APOE genetic variants on cognitive function in a cohort of older men - results from the Normative Aging Study.

Authors:  Diddier Prada; Elena Colicino; Melinda C Power; David G Cox; Marc G Weisskopf; Lifang Hou; Avron Spiro Iii; Pantel Vokonas; Jia Zhong; Marco Sanchez-Guerra; Luis A Herrera; Joel Schwartz; Andrea A Baccarelli
Journal:  BMC Psychiatry       Date:  2014-08-01       Impact factor: 3.630

8.  The algorithm for Alzheimer risk assessment based on APOE promoter polymorphisms.

Authors:  Anna Limon-Sztencel; Beata S Lipska-Ziętkiewicz; Magdalena Chmara; Bartosz Wasag; Leszek Bidzan; Beata R Godlewska; Janusz Limon
Journal:  Alzheimers Res Ther       Date:  2016-05-19       Impact factor: 6.982
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.